 After successful percutaneous coronary intervention PCI for acute myocardial infarction, 100 patients are randomly assigned to either a control group n50 who receives an optimal medical treatment, or a bone-marrow-cell group n50 who receives an optimal medical treatment and intracoronary transfer of autologous bone-marrow cells 710 days after PCI. 